KS_Logo_Color_Transparent_Bkgd

 

 

 

For Immediate Release

 

Yvonne M. Psaila

Director of Marketing & Communications

Keystone Symposia on Molecular & Cellular Biology

+ 1 970-262-2676

yvonnep@keystonesymposia.org

 

 

Keystone Symposia to Hold Free, Live, Filmed Panel Discussion on the Genome Editing Revolution

                                                                                                                                                           

SILVERTHORNE, CO – November 2, 2016 – Keystone Symposia will hold a live panel discussion on “The Genome Editing Revolution: Translating Genome Editing Technologies into Human Therapies” on Thursday, November 10, 2016 at 3 PM EST. The 90-minute event will take place at WGBH Studios in Boston, Massachusetts and will be filmed for streaming broadcast in real time to a live, global audience. Both invited members of the in-studio audience and those watching via webcast will be able to ask questions of the panelists.

 

The discussion will be moderated by Dr. J. Keith Joung of Massachusetts General Hospital and Harvard Medical School. Joining him on the panel will be Dr. Alexandra Glucksmann, Chief Operating Officer of Editas Medicine; Dr. Mike Holmes, Vice President of Research at Sangamo BioSciences; Dr. Rachel Haurwitz, CEO of Caribou Biosciences; and Dr. James Wilson of the Perelman School of Medicine at the University of Pennsylvania. The webcast portion is free and open to all, though will be of most interest to those with a scientific background.

 

Sponsored by Editas Medicine, the event will focus on identifying the areas of greatest promise and challenge to translate genome editing technologies into therapeutics to treat and potentially cure human genetic diseases. Also to be discussed will be the CRISPR intellectual property patent debate and the role that is playing in the field. The controversy has raised the profile of genome editing throughout the world, including in the lay media. This is proving to be both a benefit and burden. Perhaps no other scientific breakthrough of the past few decades has garnered as much anticipation and excitement as genome editing.

 

 

About Keystone Symposia on Molecular and Cellular Biology

 

Keystone Symposia on Molecular and Cellular Biology, a 501(c)(3) nonprofit organization, has been conducting internationally renowned, open scientific conferences since its founding as UCLA Symposia in 1972 and has been headquartered in Summit County, Colorado, USA since 1990.

 

It will convene 60 conferences in the 2016-2017 season, the majority of which will take place between January and April 2017, on topics ranging from cancer and immunology to neuroscience and genomics. Registration fees are supplemented by generous financial support from corporate, foundation and individual donors as well as government grants.

 

In January 2017, Keystone Symposia will convene a full four-day scientific research conference on “Precision Genome Engineering” in Breckenridge, Colorado organized by Drs. J. Keith Joung, Emanuelle Charpentier and Olivier Danos.

 

In the past three years, Keystone Symposia has introduced a series of shorter “virtual” events to bring the life sciences to a broader global audience, including those in low and middle-income countries who may not be able to afford from a cost or time standpoint to attend multi-day conferences in person. The Genome Editing panel is one of these events.

 

More information on the free genome editing event can be found at www.keystonesymposia.org/vks and on the organization and conferences at www.keystonesymposia.org and www.keystonesymposia.org/meetings. More details on the “Precision Genome Engineering” conference in January 2017 can be found at www.keystonesymposia.org/17A2.

 

Members of the media who would like to attend the Boston event in person should contact Yvonne Psaila, Director of Marketing and Communications at Keystone Symposia.

 

 

 

###